Impaired FHIT expression characterizes serous ovarian carcinoma

This publication has 29 references indexed in Scilit:

• Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.
  1998
• Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
  1998
• Diadenosine oligophosphates (Ap_nA), a novel class of signalling molecules?
  FEBS Letters, 1998
• AberrantFHIT transcripts in squamous cell carcinoma of the uterine cervix
  International Journal of Cancer, 1998
• Evaluation of FHIT gene alterations in ovarian cancer
  British Journal of Cancer, 1998
• Expression of abnormal transcripts of the FHIT (Fragile Histidine Triad) gene in ovarian carcinoma
  European Journal Of Cancer, 1998
• Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
  1997
• Variable FHIT transcripts in non‐neoplastic tissues
  Genes, Chromosomes and Cancer, 1997
• Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
  1996
• K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary.
  1991